CRISPR-Cas9 screening develops an epigenetic and transcriptional gene signature for risk stratification and target prediction in neuroblastoma
Liaoran Zhang(Shanghai Jiao Tong University), Kezhe Tan(Shanghai Jiao Tong University)
Cited by 2
Related Papers
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
|Journal of Experimental & Clinical Cancer Research|2022|13